Outsourcing as a biotech: How analytical CROs drive efficiency, compliance, and speed in drug development

by AMSbiopharma

Outsourcing analytical development, more than a cost-saving mechanism, has become a strategic lever that shapes data quality, regulatory confidence, and development speed. When aligned correctly, anal...

Read more

CAR-T ARI-0001 shows high response rates in adult patients with acute lymphoblastic leukemia

by Fundació Clínic per a la Recerca Biomèdica

A multidisciplinary Clínic-IDIBAPS team, part of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has published phase 2 results of the CAR-T ARI-0001 (varnimcabtagene autoleucel) for treating...

Read more

ORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadademstat in extensive stage small cell lung cancer

by Oryzon Genomics

Oryzon Genomics announced today that the first patient has been dosed in an investigator-initiated Phase Ib dose-finding trial evaluating iadademstat, Oryzon’s potent and selective LSD1 inhibitor, i...

Read more

ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS

by Oryzon Genomics

Oryzon Genomics, a clinical-stage biopharmaceutical company and global leader in epigenetics, today announced the appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer, CNS Program...

Read more

El papel esencial de los estudios preclínicos no regulatorios en el descubrimiento de fármacos

by MEDINA

El camino que recorre un compuesto bioactivo antes de convertirse en un medicamento seguro y eficaz es largo, complejo y altamente regulado. Antes de avanzar a las fases clínicas, todo candidato debe...

Read more

Pharmacelera raises €6 million to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform

by Bio&Tech Smart Capital

Pharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery based at the Barcelona Science Park (PCB-UB), has closed a €6 million investm...

Read more

ORYZON to participate in upcoming events in February and March

by Oryzon Genomics

Oryzon Genomics, a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events

Read more

Laminar Pharmaceuticals en la 'Gliobastoma Drug Development summit' (GDDS)

by Laminar Pharma

En este importante evento el LAM561 es el único fármaco que está actualmente en un estadio de investigación tan avanzado como es el final de la fase clínica 3 y que se dirige a primera línea de ...

Read more

An International Study Provides Long-Term Evidence on Bimekizumab in Plaque Psoriasis

by Hospital de la Santa Creu i Sant Pau

Un ensayo clínico internacional con seguimiento a tres años, cuyos resultados han sido publicados en JAMA Dermatology, aporta nueva evidencia sobre la evolución a largo plazo de pacientes con psori...

Read more

ORYZON receives European Medicines Agency approval to initiate a Phase II study of iadademstat in essential thrombocythemia

by Oryzon Genomics

Oryzon Genomics ha anunciado hoy que la Agencia Europea del Medicamento ha aprobado su Solicitud de Autorización de Ensayo Clínico para iniciar un ensayo clínico de Fase II de iadademstat, el inhi...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream